EIN 46-1681862

OpenBiome

IRS 501(c) type
501(c)(3)
Num. employees
23
City
Year formed
2013
Most recent tax filings
2023-12-01
Description
OpenBiome seeks to expand safe access to fecal microbiota transplantation and catalyze research into the human microbiome. It aims to eliminate practical barriers to FMT for treating recurrent C. difficile infection, ensuring safe and convenient access for those in need. OpenBiome also accelerates research on the human microbiome by offering tailored fecal microbiota samples, strains, and isolates to researchers, along with bioinformatics and analytical services. Its location is in Cambridge, MA.
Also known as...
Microbiome Health Research Institute
Total revenues
$4,376,048
2023
Total expenses
$3,509,776
2023
Total assets
$9,964,560
2023
Num. employees
23
2023

Program areas at OpenBiome

Aligned with current fda policy, Openbiome remains committed to ensuring that all patients suffering from c. difficile infection continue to have safe, convenient, and affordable access to fecal microbiota transplantation (fmt) through their physician. In our collaboration with the university of Minnesota (umn), under an active investigational drug application (ind), we continue to distribute fmt to our clinical network and are working with fda to ensure that all regulatory filings are kept current and compliant with the existing policy and guidance. We strive to make the path to treatment as simple as possible for patients and their doctors, while bringing a level of safety and standardization to the process that has set the standard for this emerging field. Openbiome provides fmt that has been manufactured by umn and has been rigorously screened. These ready-to-use fecal microbiota preparations allow physicians to devote their time and energy to treating patients, rather than the complexities of managing a stool donor program.
The global Microbiome conservancy (gmbc) program at Openbiome partners with scientists around the world to conserve, study, and share underrepresented and at-risk human Microbiome diversity. The gmbc has established a network of 80+ researchers in over three dozen countries and built a diverse collection of samples and bacterial isolates to spark scientific discovery and enable new solutions to microbiome-associated disease.the gmbc was established to solve the urgent need for a deeper, more globally representative understanding of the human Microbiome that addresses the Health concerns of all. A deeper understanding of the human Microbiome is critical to solving global Health challenges such as antimicrobial resistance, malnutrition, depression, as well as autoimmune and metabolic disorders that are linked to the communities of bacteria that live within us. However, our current body of knowledge, largely based on u.s. and european populations, is biased and vastly incomplete. As industrialization disrupts human Microbiome diversity on a global scale, the window of opportunity to study and apply the full potential of the human Microbiome is closing.to radically expand scientists' view of the Microbiome, the gmbc program has built a globally representative collection of human Microbiome samples, bacterial isolates, and associated metadata as a resource for the Research community. Working with local scientists around the world, we collect and conserve Microbiome samples (primarily gut, but also mouth, skin and other body sites) from participating communities. These samples are then characterized and, from them, the gmbc generates bacterial isolates. Resulting Research materials and associated data are shared through the gmbc collectionthe most globally representative collection of its kind that provides scientists access to previously unavailable biodiversity.in november 2023, Openbiome began the transfer of the global Microbiome conservancy program to kiel university. Openbiome remains a funder of the program and agreed to distribute a maximum of four (4) grants up to $50,000 each to in-country collaborators in the 2024 collection pipeline.
Clinical Research program: Openbiome seeks to enable translational Research on the human Microbiome. To do so, we provide a suite of services to help investigators uncover the role of the gut Microbiome in human Health, and to discover how engineering it can drive better Health outcomes. Our services include the provision of customized fecal microbiota preparations, study design and regulatory support for clinical trials, and bioinformatics and analytical services. Openbiome also sponsors its own studies investigating critical microbiome-related Health conditions.

Who funds OpenBiome

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
Child Relief International FoundationCharitable$50,000
Neil and Anna Rasmussen FoundationUnrestricted Contribution$11,919

Personnel at OpenBiome

NameTitleCompensation
Julie Barrett O'BrienChief Executive Officer
Ken LindeChief Operating Officer$197,254
Paul LeechChief Administrative Officer$59,792
Majdi OsmanChief Medical Officer$194,312
Paul MillerChief Scientific Officer
...and 18 more key personnel

Financials for OpenBiome

RevenuesFYE 12/2023
Total grants, contributions, etc.$785,396
Program services$22,100
Investment income and dividends$233,309
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$76,103
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$3,259,140
Miscellaneous revenues$0
Total revenues$4,376,048

Form 990s for OpenBiome

Fiscal year endingDate received by IRSFormPDF link
2023-122024-11-15990View PDF
2022-122023-11-15990View PDF
2021-122022-11-10990View PDF
2020-122021-11-05990View PDF
2019-122021-03-02990View PDF
...and 6 more Form 990s
Data update history
February 8, 2025
Posted financials
Added Form 990 for fiscal year 2023
January 14, 2025
Received grants
Identified 1 new grant, including a grant for $11,919 from Neil and Anna Rasmussen Foundation
November 21, 2024
Updated personnel
Identified 1 new personnel
October 18, 2024
Updated personnel
Identified 5 new personnel
January 9, 2024
Posted financials
Added Form 990 for fiscal year 2022
Nonprofit Types
Grantmaking organizationsDisease research fundraisersHealth organizationsCharities
Issues
HealthDiseases and disordersPublic policy
Characteristics
Conducts researchOperates internationallyReceives government fundingTax deductible donationsAccepts online donations
General information
Address
400 W Cummings Park PMB 203 17
Woburn, MA 01801
Metro area
Boston-Cambridge-Newton, MA-NH
County
Middlesex County, MA
Website URL
openbiome.org/ 
Phone
(617) 575-2201
IRS details
EIN
46-1681862
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2013
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
E05: Health Care Research Institutes and Public Policy Analysis
NAICS code, primary
813212: Health and Disease Research Fundraising Organizations
Parent/child status
Independent
California AB-488 details
AB 488 status
Undetermined
Charity Registration status
Not Registered
FTB status revoked
Revoked
AG Registration Number
None yet
FTB Entity ID
3690283
AB 488 data last updated ("as-of") date
2025-02-19
Free account sign-up

Want updates when OpenBiome has new information, or want to find more organizations like OpenBiome?

Create free Cause IQ account